Long-term renal outcome and complications in South Africans with proliferative lupus nephritis

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1289-1300

  Ayodele, Olugbenga E ^a   Okpechi, Ikechi G ^b   Swanepoel, Charles R ^b  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Complication; Proliferative lupus nephritis; Renal outcome; South Africans

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GASTRITIS; GLOMERULUS FILTRATION RATE; HERPES ZOSTER; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; LEUKEMIA; LONGITUDINAL STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OVARY INSUFFICIENCY; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; SEPSIS; SOUTH AFRICA; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; BLOOD PRESSURE; CREATININE; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; METHYLPREDNISOLONE; PREDNISONE; PROTEINURIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SURVIVAL RATE; TIME FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84887106246     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0376-9     Document Type: Article

References (28)

1. Waldman W, Appel GB (2006) Update in the treatment of lupus nephritis. Kidney Int 70:1403-1412
2. Bongu A, Chang E, Ramsey-Goldman R (2002) Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 16(2):313-332
3. Mok CC (2005) Prognostic factors in lupus nephritis. Lupus 14:39-44
4. Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology 46:1487-1491
5. Churg J, Bernstein J, Glassock RJ (1995) Renal disease: Classification and Atlas of Glomerular Disease. Tokyo, Igaku-Shoin, pp 151-179
6. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C et al (2005) Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14:890-895
7. Mok CC, Wong RWS, Lau CS (1999) Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis 34(2):315-323
8. Ayodele OE, Okpechi IG, Swanepoel CR (2010) Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis. Nephrology 15:482-490
9. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS et al (2006) Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119:355.e25-355.e33
10. Dooley MA, Hogan S, Jennette C, Falk R, Glomerular Disease Collaborative Network (1997) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Kidney Int 51:1188-1195
11. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
12. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1):S1-S266
13. Seedat YK, Croasdale MA, Milne FJ et al (2006) Guideline Committee, Southern African Hypertension Society; Directorate: Chronic Diseases, Disabilities and Geriatrics, National Department of Health. South African Hypertension guideline 2006. S Afr Med J 96(4 Pt 2):337-362
14. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2006) The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 54:421-432
15. Cortés-Hernández J, Ordi-Ros J, Labrador M et al (2003) Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus 12:287-296
16. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, Lupus Nephritis Collaborative Study Group (2000) Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 35(5):904-914
17. Moroni G, Quaglini S, Galleli B, Banfi G, Messa P, Ponticelli C (2007) The long term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant 22:2531-2539
18. Mok CC, Ying KY, Tang S et al (2004) Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheum 50:2559-2568
19. Nossent HC, Koldingsnes W (2000) Long-term efficacy of azathioprine treatment for proliferative lupus nephritis. Rheumatology 39:969-974
20. Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D (2009) The health and health system of South Africa: historical roots of current public health challenges. Lancet 374:817-834
21. du Huong L, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide: A study in 84 patients. J Rheumatol 29:2571-2576
22. Chan TM, Tse KC, Tang CSO, Lai KN, Li FK (2005) Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. Lupus 14:265-272
23. Hou CL, Tsai YC, Chen LC, Huang JL (2008) Tuberculosis infection in patients with systemic lupus erythematosus; Pulmonary and extra-pulmonary infection compared. Clin Rheumatol 27:557-563
24. Sayarlioglu M, Inanc M, Kamali S et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274-278
25. Austin HA III, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689-695
26. Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA (1989) The Lupus Nephritis Collaborative Study Group: the predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 36:891-896
27. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ, Lupus Nephritis Collaborative Study Group (1992) Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 42:743-748
28. Weening JJ, D'Agati VD, Schwartz MM et al. International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus nephritis re-visited. J Am Soc Nephrol 15:241-250 (Erratum: J Am Soc Nephrol 2004; 15:835-836)